Market Tracker

03/24 12:03pm ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

3.27
Delayed Data
As of 11:38am ET
 +0.0399 / +1.24%
Today’s Change
1.62
Today|||52-Week Range
5.79
+22.47%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close3.23
Today’s open3.21
Day’s range3.18 - 3.27
Volume11,501
Average volume (3 months)149,571
Market cap$154.6M
Dividend yield--
Data as of 11:38am ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-269.23%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-6.38%
P/E ratioNM
Price/Sales44.43
Price/Book--

Competitors

 Today’s
change
Today’s
% change
COCPCocrystal Pharma Inc+0.01+2.37%
SMMTSummit Therapeutics ...-0.11-0.87%
NEOSNeos Therapeutics In...-0.10-1.43%
REPHRecro Pharma Inc+0.04+0.50%
Data as of 12:02pm ET, 03/24/2017

Financials

Last reporting dateMarch 11, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$2.8M
Annual profit (last year)-$17.9M
Net profit margin-647.67%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
Erik Danielsen
Corporate headquarters
Saint-Laurent, Quă©bec

Forecasts